Nov 5 • 📈 A.I. TRADING CHAT
Trump’s Weight-Loss Drug Deal: The Healthcare Shockwave
🚨 Breaking Catalyst for Thursday:
President Trump is set to announce a $38B government partnership with Eli Lilly (LLY) and Novo Nordisk (NVO) to make weight-loss drugs available at $150/month — a move that could reshape the entire healthcare sector.
What This Means for Traders:
💊 Eli Lilly (LLY) is already up nearly 5% ahead of the announcement.
🔥 Entry Zone: $920–935 | Target: $1,025 | Stop: $895
💥 Novo Nordisk (NVO) following as a sympathy play — entry $46–47.50, targeting $51–54.50.
📈 Healthcare sector rotation is in full swing as tech money flows into pharma.
Why It Matters:
This isn’t just a “news bump.” It’s a policy-backed volume catalyst that could spark weeks of momentum. Institutions are already loading up ahead of the announcement.
💬 Question for the community:
Are you playing the Trump–Lilly–Novo setup or waiting for confirmation after 11 AM EST?
What’s your strategy for riding this momentum safely?
1
1 comment
Trump’s Weight-Loss Drug Deal: The Healthcare Shockwave
skool.com/ai-trading
🔹 Learn to trade crypto & options with AI. Share prompts, get weekly trade plans, and join live trading sessions.
Leaderboard (30-day)
1
+52
2
+1
Powered by